Bordetella petrii infection with long-lasting persistence in human

Emerging Infectious Diseases

Volumn 17, Issue 4, 2011, Pages 612-618

  le Coustumier, Alain ^a   Njamkepo, Elisabeth ^b   Cattoir, Vincent ^c   Guillot, Sophie ^b   Guiso, Nicole ^b  

^a CENTRE HOSPITALIER   (France)

^b INSTITUT PASTEUR   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DORIPENEM; ERTAPENEM; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TOBRAMYCIN;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BORDETELLA; BORDETELLA PETRII; BORDETELLOSIS; BREATHING EXERCISE; BRONCHIECTASIS; CASE REPORT; COUGHING; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; DYSPNEA; FEMALE; GENE AMPLIFICATION; HEART INFARCTION; HUMAN; HYPONATREMIA; LUNG LOBECTOMY; LUNG TUBERCULOSIS; MEDICAL HISTORY; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; POSTPRIMARY TUBERCULOSIS; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY FAILURE; SCHWARTZ BARTTER SYNDROME; SPUTUM CULTURE; TREATMENT OUTCOME;

EID: 79953729626     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1704.101480     Document Type: Article

References (38)

1. von Wintzingerode F, Schattke A, Siddiqui RA, Rosick U, Göbel UB, Gross R. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol. 2001;51:1257-1265.
2. Ko KS, Peck KR, Oh WS, Lee NY, Lee JH, Song JH. New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst. J Clin Microbiol. 2005;43:2516-2519. DOI: 10.1128/JCM.43.5.2516-2519.2005
3. Fry NK, Duncan J, Malnick H, Cockcroft PM. The first UK isolate of 'Bordetella ansorpii' from an immunocompromised patient. J Med Microbiol. 2007;56:993-995. DOI: 10.1099/jmm.0.47078-0
4. Vandamme P, Heyndricks M, Vancanneyt M, Hoste B, De Vos P, Falsen E, et al. Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of alcaligenes denitrify cans rüger and tan 1983. Int J Syst Bacteriol. 1996;46:849-858. DOI: 10.1099/00207713-46-4-849
5. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-382. DOI: 10.1128/CMR.18.2.326-382.2005
6. Cookson BT, Vandamme P, Carlson LC, Larson AM, Sheffi eld JV, Kersters K, et al. Bacteremia caused by a novel Bordetella species, "B. hinzii." J Clin Microbiol. 1994;32:2569-2571.
7. Funke G, Hess T, von Graevenitz A, Vandamme P. Characteristics of Bordetella hinzii strains isolated from a cystic fi brosis patient over a 3-year period. J Clin Microbiol. 1996;34:966-9.
8. Harrington AT, Castellanos JA, Ziedalski TM, Clarridge JE III, Cookson BT. Isolation of Bordetella avium and novel Bordetella strain from patients with respiratory disease. Emerg Infect Dis. 2009;15:72-74. DOI: 10.3201/eid1501.071677
9. Vandamme P, Hommez J, Vancanneyt M, Monsieurs M, Hoste B, Cookson B, et al. Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol. 1995;45:37-45. DOI: 10.1099/00207713-45-1-37
10. Gross R, Keidel K, Schmitt K. Resemblance and divergence: the "new" members of the genus Bordetella. Med Microbiol Immunol (Berl). 2010;199:155-163. DOI: 10.1007/s00430-010-0148-z
11. Goodnow RA. Biology of Bordetella bronchiseptica. Microbiol Rev. 1980;44:722-38.
12. Gueirard P, Weber C, Le Coustumier A, Guiso N. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol. 1995;33:2002-2006.
13. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachussetts patients with pertussis-like symptoms. Emerg Infect Dis. 1999;5:441-443. DOI: 10.3201/eid0503.990317
14. Weyant RS, Hollis DG, Weaver RE, Amin MFM, Steigerwalt AG, O'Connor SP, et al. Bordetella holmesii sp. nov., a new gramnegative species associated with septicemia. J Clin Microbiol. 1995;33:1-7.
15. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis. 1998;26:389-392. DOI: 10.1086/516323
16. Fry NK, Duncan J, Malnick H, Warner M, Smith AJ, Jackson MS, et al. Bordetella petrii clinical isolate. Emerg Infect Dis. 2005;11:1131-1133.
17. Moissenet D, Bingen E, Arlet G, Vu-Thien H. Use of 16s Rrna gene sequencing for identifi cation of "Pseudomonas-like" isolates from sputum of patients with cystic fi brosis. Pathol Biol (Paris). 2005;53:500-502. DOI: 10.1016/j.patbio.2005.06.004
18. Stark D, Riley LA, Harkness J, Marriott D. Bordetella petrii from a clinical sample in Australia: isolation and molecular identifi cation. J Med Microbiol. 2007;56:435-7. DOI: 10.1099/jmm.0.46976-0
19. Spilker T, Liwienski AA, LiPuma JJ. Identifi cation of Bordetella spp. in respiratory specimens from individuals with cystic fi brosis. Clin Microbiol Infect. 2008;14:504-506. DOI: 10.1111/j.1469-0691.2008.01968.x
20. Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, et al. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol. 2006;188:8385-8394. DOI: 10.1128/ JB.01081-06
21. Buboltz AM, Nicholson TL, Parette MR, Hester SE, Parkhill J, Harvill ET. Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. J Bacteriol. 2008;190:5502-5511. DOI: 10.1128/JB.00226-08
22. Gross R, Guzman CA, Sebaihia M, dos Santos VA, Pieper DH, Koebnik R, et al. The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic bordetellae. BMC Genomics. 2008;9:449. DOI: 10.1186/1471-2164-9-449
23. Lechner M, Schmitt K, Bauer S, Hot D, Hubans C, Levillain E, et al. Genomic island excisions in Bordetella petrii. BMC Microbiol. 2009;9:141. DOI: 10.1186/1471-2180-9-141
24. Bartlett JG, Brewer NS, Ryan KJ. Cumitech 7, laboratory diagnosis of lower respiratory tract infections. In: Washington JA II, editor. Respiratory tract infections. Washington: American Society for Microbiology; 1978.
25. Référentiel en Microbiologie Médicale (RÉMIC). Diagnostic microbiologique des infections broncho-pulmonaires. In: RÉMIC vol 13. Paris: Société Française Microbiologie; 2010. p. 93-98.
26. Heininger U, Cotter PA, Fescemyer HW, Martinez De Tejada G, Yuk MH, Miller JF, et al. Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun. 2002;70:3777-3784. DOI: 10.1128/IAI.70.7.3777-3784.2002
27. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet. 2003;35:32-40. DOI: 10.1038/ng1227
28. Njamkepo E, Delisle F, Hagege I, Gerbaud G, Guiso N. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect. 2000;6:131-136. DOI: 10.1046/j.1469-0691.2000.00032.x
29. Edwards U, Rogall T, Blocker H, Emde M, Bottger EC. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res. 1989;17:7843-7853. DOI: 10.1093/nar/17.19.7843
30. Janvier M, Grimont PA. The genus Methylophaga, a new line of descent within phylogenetic branch gamma of proteobacteria. Res Microbiol. 1995;146:543-550. DOI: 10.1016/0923-2508(96)80560-2
31. Thompson JD, Higgins DG, Gibson TJ. Clustal w: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specifi c gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673-4680. DOI: 10.1093/ nar/22.22.4673
32. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing-twentieth informational supplement: approved standard m100-s120. Wayne (PA): The Institute; 2010.
33. Comité de l'Antibiogramme de la Société Française de Microbiologie C. 2010 [cited 2011 Feb 15]. http://nosobase.chu-lyon.fr/ recommandations/sfm/2010_antibiotiques_casfm.pdf
34. Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, et al. Pulsed-fi eld gel electrophoresis analysis of Bordetella pertussis populations in various european countries with different vaccine policies. Microbes Infect. 2005;7:976-9782. DOI: 10.1016/j.micinf.2005.04.005
35. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun. 1993;61:486-90.
36. Bassinet L, Gueirard P, Maitre B, Housset B, Gounon P, Guiso N. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun. 2000;68:1934-1941. DOI: 10.1128/IAI.68.4.1934-1941.2000
37. Zbinden A, Böttger EC, Bosshard PP, Zbinden R. Evaluation of the colorimetric VITEC 2 card for identifi cation of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing. J Clin Microbiol. 2007;45:2270-3. DOI: 10.1128/JCM.02604-06
38. Hill BC, Baker CN, Tenover FC. A simplifi ed method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol. 2000;38:1151-1155.